Fund
Omnes Capital
Omnes Capital followed on in the round of WhiteLab Genomics (26 M$, Series B) on 6 October 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 0
- New entries
- 0
- Follow ons
- 1
- Latest operation
- 6 October 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 06 Oct | France, Biotech | Series B | 26 M$ | Existing investor |
Co investors 4 funds crossed
- AVP 1 operation
- Blast Club 1 operation
- Debiopharm Innovation Fund 1 operation
- Yaday Health 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: France.